v3.26.1
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 212,563 $ 617,835 $ 596,287 $ 1,898,976
Selling, general and administrative (including related party amounts of $428,966 and $619,549 for the three and six months ended June 30, 2026, respectively, and $0 for the three and six months ended June 30, 2025) 2,801,004 1,154,896 4,343,662 2,213,559
Total operating expenses 3,013,567 1,772,731 4,939,949 4,112,535
Loss from operations (3,013,567) (1,772,731) (4,939,949) (4,112,535)
Other income and expenses:        
Interest income 46,504 71,638 125,180 107,855
Net loss $ (2,967,063) $ (1,701,093) $ (4,814,769) $ (4,004,680)
Net loss per share of Common Stock, basic $ (0.74) $ (1.22) $ (1.66) $ (5.18)
Net loss per share of Common Stock, diluted $ (0.74) $ (1.66) $ (1.22) $ (5.18)
Weighted-average basic Common Stock 4,022,143 1,026,506 3,940,983 772,397
Weighted-average diluted Common Stock 4,022,143 1,026,506 3,940,983 772,397